mRNA vaccine manufacturers loathe to share know-how
In contrast, 54% of the total population in the U.S. is fully vaccinated. After approving booster shots for the immunocompromised people, on September 22, the U.S. FDA greenlighted booster shots…
Category: South Africa
Reneging on the ‘no-profit pledge’ to supply Oxford vaccine
On the say day the release was sent out announcing the partnership with AstraZeneca, Oxford University also tweeted saying that the vaccine will be manufactured and distributed “on a not-for-profit basis…
Editorial: An ominous situation
That the medicine chest is bereft of effective new drugs to fight the extremely drug-resistant tuberculosis (XDR-TB) strain has once again become frighteningly clear. According to a study published recently…
‘Long-term outcomes in South African patients with XDR-TB poor’
Long-term outcomes in South African patients who have extremely-drug resistant tuberculosis (XDR-TB) are “poor” immaterial of HIV status, notes a paper published on January 17 in The Lancet . Despite…
‘Nuances of childhood TB are never taught in medical schools’
If diagnosing tuberculosis in children, particularly those aged under five years, is fraught with problems, health-care workers at different levels who are unaware of the latest advancements in childhood TB…
Second-line TB drugs: ‘It is more difficult to assess adverse effects in children’
Prof. H. Simon Schaaf, a clinical researcher from the Department of Paediatrics and Child Health, Faculty of Health Sciences, Desmond Tutu TB Centre, Stellenbosch University, South Africa has worked…
‘Children metabolise TB drugs much faster than adults’
Dr. Peter R. Donald, Emeritus Professor in the Department of Paediatrics and Child Health of the Faculty of Health Sciences at Stellenbosch University, South Africa was awarded an A-rating…
Malnourished children in India below three years are underdosed for first-line TB drugs
“The ultimate goal of evidence-based drug treatment is to produce a desired pharmacological response in a predictable manner and also to minimise adverse effects,” notes a June 2013 paper published…
